Literature DB >> 25204502

Potential role of myeloid cell/eosinophil-derived IL-17 in LPS-induced endotoxin shock.

Eri Shimura1, Akiko Shibui2, Seiko Narushima3, Aya Nambu3, Sachiko Yamaguchi3, Aoi Akitsu4, Warren J Leonard5, Yoichiro Iwakura4, Kenji Matsumoto6, Hajime Suto1, Ko Okumura1, Katsuko Sudo7, Susumu Nakae8.   

Abstract

IL-17RA is a shared receptor subunit for several cytokines of the IL-17 family, including IL-17A, IL-17C, IL-17E (also called IL-25) and IL-17F. It has been shown that mice deficient in IL-17RA are more susceptible to sepsis than wild-type mice, suggesting that IL-17RA is important for host defense against sepsis. However, it is unclear which ligands for IL-17RA, such as IL-17A, IL-17C, IL-17E/IL-25 and/or IL-17F, are involved in the pathogenesis of sepsis. Therefore, we examined IL-17A, IL-17E/IL-25 and IL-17F for possible involvement in LPS-induced endotoxin shock. IL-17A-deficient mice, but not IL-25- or IL-17F-deficient mice, were resistant to LPS-induced endotoxin shock, as compared with wild-type mice. Nevertheless, studies using IL-6-deficient, IL-21Rα-deficient and Rag-2-deficient mice, revealed that neither IL-6 and IL-21, both of which are important for Th17 cell differentiation, nor Th17 cells were essential for the development of LPS-induced endotoxin shock, suggesting that IL-17A-producing cells other than Th17 cells were important in the setting. In this connection, IL-17A was produced by macrophages, DCs and eosinophils after LPS injection. Taken together, these findings indicate that IL-17A, but not IL-17F or IL-25, is crucial for LPS-induced endotoxin shock. In addition, macrophages, DCs and eosinophils, but not Th17 cells or γδ T cells, may be sources of IL-17A during LPS-induced endotoxin shock.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IL-17A; IL-17F; IL-25; Sepsis

Mesh:

Substances:

Year:  2014        PMID: 25204502      PMCID: PMC4250284          DOI: 10.1016/j.bbrc.2014.09.004

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

1.  A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity.

Authors:  Y Shi; S J Ullrich; J Zhang; K Connolly; K J Grzegorzewski; M C Barber; W Wang; K Wathen; V Hodge; C L Fisher; H Olsen; S M Ruben; I Knyazev; Y H Cho; V Kao; K A Wilkinson; J A Carrell; R Ebner
Journal:  J Biol Chem       Date:  2000-06-23       Impact factor: 5.157

2.  Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family.

Authors:  H Li; J Chen; A Huang; J Stinson; S Heldens; J Foster; P Dowd; A L Gurney; W I Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Adoptive transfer of in vitro-stimulated CD4+CD25+ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis.

Authors:  Josef G Heuer; Tonghai Zhang; Jingyong Zhao; Chunjin Ding; Martin Cramer; Kathy L Justen; Steven L Vonderfecht; Songqing Na
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

4.  Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture.

Authors:  D G Remick; D E Newcomb; G L Bolgos; D R Call
Journal:  Shock       Date:  2000-02       Impact factor: 3.454

5.  Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection.

Authors:  S A Dalrymple; R Slattery; D M Aud; M Krishna; L A Lucian; R Murray
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

6.  Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production.

Authors:  Mee Rhan Kim; Raffi Manoukian; Richard Yeh; Scott M Silbiger; Dimitry M Danilenko; Sheila Scully; Jilin Sun; Margaret L DeRose; Marina Stolina; David Chang; Gwyneth Y Van; Kristie Clarkin; Hung Q Nguyen; Yan Bin Yu; Shuqian Jing; Giorgio Senaldi; Gary Elliott; Eugene S Medlock
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

7.  A critical role for IL-21 in regulating immunoglobulin production.

Authors:  Katsutoshi Ozaki; Rosanne Spolski; Carl G Feng; Chen-Feng Qi; Jun Cheng; Alan Sher; Herbert C Morse; Chengyu Liu; Pamela L Schwartzberg; Warren J Leonard
Journal:  Science       Date:  2002-11-22       Impact factor: 47.728

8.  Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses.

Authors:  Susumu Nakae; Yutaka Komiyama; Aya Nambu; Katsuko Sudo; Michiko Iwase; Ikuo Homma; Kenji Sekikawa; Masahide Asano; Yoichiro Iwakura
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

9.  Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract.

Authors:  Alexander M Owyang; Colby Zaph; Emma H Wilson; Katherine J Guild; Terrill McClanahan; Hugh R P Miller; Daniel J Cua; Michael Goldschmidt; Christopher A Hunter; Robert A Kastelein; David Artis
Journal:  J Exp Med       Date:  2006-04-10       Impact factor: 14.307

10.  Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response.

Authors:  M Pasparakis; L Alexopoulou; V Episkopou; G Kollias
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

View more
  6 in total

1.  Vasoactive intestinal peptide suppresses macrophage-mediated inflammation by downregulating interleukin-17A expression via PKA- and PKC-dependent pathways.

Authors:  Wen-Zhuo Ran; Liang Dong; Chun-Yan Tang; Yong Zhou; Guo-Ying Sun; Tian Liu; Yong-Ping Liu; Cha-Xiang Guan
Journal:  Int J Exp Pathol       Date:  2015-05-05       Impact factor: 1.925

2.  Central Role of IL-23 and IL-17 Producing Eosinophils as Immunomodulatory Effector Cells in Acute Pulmonary Aspergillosis and Allergic Asthma.

Authors:  Evelyn Santos Guerra; Chrono K Lee; Charles A Specht; Bhawna Yadav; Haibin Huang; Ali Akalin; Jun R Huh; Christian Mueller; Stuart M Levitz
Journal:  PLoS Pathog       Date:  2017-01-17       Impact factor: 6.823

Review 3.  Innate Cells: The Alternative Source of IL-17 in Axial and Peripheral Spondyloarthritis?

Authors:  Nicolas Rosine; Corinne Miceli-Richard
Journal:  Front Immunol       Date:  2021-01-08       Impact factor: 7.561

Review 4.  Biology of Interleukin-17 and Its Pathophysiological Significance in Sepsis.

Authors:  Yun Ge; Man Huang; Yong-Ming Yao
Journal:  Front Immunol       Date:  2020-07-28       Impact factor: 7.561

5.  The roles of IL-17C in T cell-dependent and -independent inflammatory diseases.

Authors:  Sachiko Yamaguchi; Aya Nambu; Takafumi Numata; Takamichi Yoshizaki; Seiko Narushima; Eri Shimura; Yoshihisa Hiraishi; Ken Arae; Hideaki Morita; Kenji Matsumoto; Ichiro Hisatome; Katsuko Sudo; Susumu Nakae
Journal:  Sci Rep       Date:  2018-10-24       Impact factor: 4.379

6.  A Novel Chinese Medicine, Xinfeng Capsule, Modulates Proinflammatory Cytokines via Regulating the Toll-Like Receptor 4 (TLR4)/Mitogen-Activated Protein Kinase (MAPK)/Nuclear Kappa B (NF-κB) Signaling Pathway in an Adjuvant Arthritis Rat Model.

Authors:  Yun-Xiang Cao; Dan Huang; Jian Liu; Rui-Kai Zong; Lei Wan; Chuan-Bing Huang; Wan-Dong Zhang; Yuan Wang
Journal:  Med Sci Monit       Date:  2019-09-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.